KANAN BHATT
Family Nurse Practitioner in PRINCETON, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
KANAN BHATT filed 2,993 Medicare Part D claims in 2023 as a Family Nurse Practitioner in PRINCETON, New Jersey, prescribing 75% generic.
- 3K
- Part D claims, 2023
- 75%
- generic prescribing
- $798.39
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
KANAN BHATT's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
2,993 Top 12% higher than 88% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about KANAN BHATT?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New Jersey
How Family Nurse Practitioner compares to other specialties among New Jersey providers
Family Nurse Practitioner share within New Jersey
Family Nurse Practitioner is one of the more visible NUCC categories in New Jersey
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Family Nurse Practitioner (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Family Nurse Practitioner ABMS/AOA estimate
Est. board-certified rate (Family Nurse Practitioner) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Family Nurse Practitioner US NPIs
Specialty board-certified rate — Family Nurse Practitioner estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
KANAN BHATT appears in the CMS NPPES registry as a Family Nurse Practitioner provider at 29 RUTGERS LN, PRINCETON, NJ, 08540, with a listed phone of (609) 508-2843. NPI 1538701313 was issued on 10/12/2019. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BHATT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,993 prescription claims written by this provider, covering 200 Medicare beneficiaries and totaling roughly $1.8 million in drug spend, split 25% brand-name and 75% generic by claim count, with an opioid prescribing rate of 0.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Family Nurse Practitioner is a high-volume specialty nationwide, with 209,817 enrolled providers across 56 states and an average of 1,222 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1538701313 |
|---|---|
| Specialty | Family Nurse Practitioner |
| Gender | Female |
| NPI Issued | 10/12/2019 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm KANAN BHATT's current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where KANAN BHATT bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KANAN BHATT. Source: openpaymentsdata.cms.gov.
Total received
$798
Largest payer
Gilead Sciences, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
25% brand-name claims vs 75% generic, on 2,993 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,105
- Total Day Supply
- 118,105
- Brand vs Generic
- 25% brand / 75% generic
- Brand Drug Cost
- $1.7M
- Generic Drug Cost
- $94K
- Opioid Claims
- 26 (0.9% rate)
- Antibiotic Claims
- 65
Patient Demographics
- Average Patient Age
- 63.0 years
- Avg HCC Risk Score
- 1.54
- Gender Split
- 47% female / 53% male
- Age Distribution
- <65: 83, 65-74: 92, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What KANAN BHATT prescribes most
Top Medicare Part D drugs by claim count, 2023
- Amlodipine Besylate
Amlodipine Besylate
196 claims
- Atorvastatin Calcium
Atorvastatin Calcium
158 claims
- Biktarvy
Biktarvy
149 claims
- Metformin Hcl
Metformin Hcl
103 claims
- Genvoya
Genvoya
88 claims
- Lisinopril
Lisinopril
84 claims
- Jardiance 71
Jardiance
71 claims
- Hydrochlorothiazide 60
Hydrochlorothiazide
60 claims
| Drug | Claims |
|---|---|
| Amlodipine Besylate | 196 |
| Atorvastatin Calcium | 158 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 149 |
| Metformin Hcl | 103 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 88 |
| Lisinopril | 84 |
| Jardiance Empagliflozin | 71 |
| Hydrochlorothiazide | 60 |
| Losartan Potassium | 57 |
| Gabapentin | 56 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Nurse Practitioner Overview
How KANAN BHATT fits within the Family Nurse Practitioner landscape nationally.
KANAN BHATT's 2,993 claims are above the specialty average of 1,222.
Nearby Family Nurse Practitioner Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as BHATT.
Compare Family Nurse Practitioner nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is KANAN BHATT's specialty? ▼
How much does KANAN BHATT prescribe under Medicare Part D? ▼
Where is KANAN BHATT located? ▼
What is KANAN BHATT's NPI number? ▼
Does KANAN BHATT prescribe more brand-name or generic drugs? ▼
Does KANAN BHATT prescribe opioids? ▼
How many Family Nurse Practitioner providers are there in the US? ▼
What drugs does KANAN BHATT prescribe most often? ▼
Does KANAN BHATT accept Medicare? ▼
How can I verify KANAN BHATT's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology